Active substance
Isoflurane
- SFDA 6
- US FDA 7
- Health Canada 2
- WHO EML 1
- Safety 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| AERRANE LIQUID FOR INHALATION | Inhalation vapour, liquid · Inhalation use | 6 Bottle | SAR 406.50 | Generic · Prescription | BAXTER HEALTHCARE CORPORATION | Valid | |
| TERRELL 100% VAPOUR LIQUID FOR INHALATION | 100 % | Inhalation vapour, liquid · Inhalation use | 1 Inhaler | SAR 41.10 | NCE · Prescription | Gulf Pharmaceutical Industries (Julphar) | Valid |
| FLORAN | 100 ml | inhalation solution · Inhalation use | 1 Bottle | SAR 61.00 | Generic · Prescription | Hikma Pharmaceuticals PLC | Withdrawn by MAH · Not Marketed |
| FORANE(INH. ANES.)100ML BOTTL | inhalation solution · Inhalation use | 1 Bottle | SAR 247.65 | NCE · Prescription | Abbott Laboratories | Withdrawn by MAH · Not Marketed | |
| FORANE(INH. ANES.)100ML BOTTL | inhalation solution · Inhalation use | 1 Bottle | SAR 619.10 | NCE · Prescription | Abbott Laboratories | Withdrawn by MAH · Not Marketed | |
| TERRELL 100% VAPOUR LIQUID FOR INHALATION | 100 % | Inhalation vapour, liquid · Inhalation use | 1 Inhaler | SAR 41.10 | NCE · Prescription | PIRAMAL CRITICAL CARE INC | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ANESTHESIA
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| FORANE | 99.9% | liquid · inhalation | BAXTER HLTHCARE | Prescription | 18 Dec 1979 |
| ISOFLURANE | 99.9% | liquid · inhalation | PIRAMAL CRITICAL | Prescription | 30 Sep 1994 |
| ISOFLURANE | 99.9% | liquid · inhalation | PIRAMAL PHARMA | Prescription | 27 Jun 1995 |
| ISOFLURANE | 99.9% | liquid · inhalation | HALOCARBON PRODS | Prescription | 20 Oct 1999 |
| ISOFLURANE | 99.9% | liquid · inhalation | SHANDONG | Prescription | 4 Nov 2025 |
| ISOFLURANE | 99.9% | liquid · inhalation | HOSPIRA | Discontinued | 25 Jan 1993 |
| ISOFLURANE | 99.9% | liquid · inhalation | WATSON LABS INC | Discontinued | 12 May 1995 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| FORANE | 02188856 | 100 % | LIQUID · INHALATION | BAXTER CORPORATION |
| ISOFLURANE USP | 02231929 | 99.9 % | LIQUID · INHALATION | FRESENIUS KABI CANADA LTD |
WHO WHO Model List of Essential Medicines (2025)
- 1.1.1. General anaesthetics and oxygen > Inhalational medicines · core
Anaesthetics and therapeutic gases
Respiratory > Inhalation > liquid:
Safety signals and safety-related labeling changes
- US FDA 9 Dec 2024 FORANE — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.